D dimer News and Research

RSS
Cardiovascular disease in COVID-19

Cardiovascular disease in COVID-19

Five biomarkers in blood linked to higher odds of clinical deterioration, death in COVID-19 patients

Five biomarkers in blood linked to higher odds of clinical deterioration, death in COVID-19 patients

Research explains recognized sex differences in COVID-19 outcomes

Research explains recognized sex differences in COVID-19 outcomes

New simple way of detecting COVID-19 in blood plasma

New simple way of detecting COVID-19 in blood plasma

Platelet hyperreactivity, a unique feature of COVID-19

Platelet hyperreactivity, a unique feature of COVID-19

Researchers identify anticoagulation agent that suppresses SARS-CoV-2 replication in vitro

Researchers identify anticoagulation agent that suppresses SARS-CoV-2 replication in vitro

Prednisone, Hydroxychloroquine best among COVID-19 treatments, claims large Spanish study

Prednisone, Hydroxychloroquine best among COVID-19 treatments, claims large Spanish study

SphingoTec introduces a CE-IVD-marked point-of-care test to determine blood levels of bio-ADM

SphingoTec introduces a CE-IVD-marked point-of-care test to determine blood levels of bio-ADM

New guideline can help clinicians identify hard-to-diagnose acute aortic syndrome

New guideline can help clinicians identify hard-to-diagnose acute aortic syndrome

Clots, COVID-19 and survival

Clots, COVID-19 and survival

Study: Cellular therapy can improve critical cases of COVID-19

Study: Cellular therapy can improve critical cases of COVID-19

Research sheds light on mysterious COVID-19 related hyperinflammatory shock in children

Research sheds light on mysterious COVID-19 related hyperinflammatory shock in children

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

Markers of vascular damage in COVID-19

Markers of vascular damage in COVID-19

HORIBA Medical white paper provides a review of hematology biomarkers for COVID-19 assessment

HORIBA Medical white paper provides a review of hematology biomarkers for COVID-19 assessment

8.5 percent of COVID-19 patients do not seroconvert

8.5 percent of COVID-19 patients do not seroconvert

Researchers find prothrombotic antibodies in patients with COVID-19

Researchers find prothrombotic antibodies in patients with COVID-19

Deep vein thrombosis common in patients with moderate to severe COVID-19

Deep vein thrombosis common in patients with moderate to severe COVID-19

Tocilizumab in Critical COVID-19 Patients

Tocilizumab in Critical COVID-19 Patients

Tocilizumab in COVID-19 patients on mechanical ventilation

Tocilizumab in COVID-19 patients on mechanical ventilation